A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2006
12/27/2006	CN1883469A An ocular microemulsion containing Vitamin A and Vitamin E and preparation method thereof
12/27/2006	CN1883468A A pharmaceutical composition containing sodium tanshinon II A silate
12/27/2006	CN1883467A Orally administered anti-tumor medicinal composition of taxane and administration method thereof
12/27/2006	CN1883466A Preparation process of paclitaxel injection
12/27/2006	CN1883465A Apoferritin ¿Cplatinum anticancer drug composition and preparation method thereof
12/27/2006	CN1883464A Ophthalmic preparation containing sodium new houttuyfonate
12/27/2006	CN1883463A Use of ¿C(4-hydroxy-3-methoxyphenyl)-7-(4- hydroxyphenyl)-3,5-dihydroxy heptane
12/27/2006	CN1883462A Nicotine transdermal delivery system
12/27/2006	CN1883461A Sustained-releasing oral mucosa medicinal film
12/27/2006	CN1883460A An enteric coated mini-pill of pantoprazole sodium
12/27/2006	CN1883459A Enteric coated preparation of entecavir and preparation method thereof
12/27/2006	CN1883458A Enteric coated preparation of lansoprazole sodium and preparation method thereof
12/27/2006	CN1883457A Lyophilized suspended powder injection and preparation method thereof
12/27/2006	CN1883456A Flavor-hidden pharmaceutical granule, preparation method and use thereof
12/27/2006	CN1883455A A long-circulating nanoliposome carrier of hydroxycamptothecine and preparation method thereof
12/27/2006	CN1883454A Liposome administration system with tumor necrosis targeted antibody for preposition and application thereof
12/27/2006	CN1883452A An angiogenesis inhibitor and synergist thererof co-carried sustained-release anticancer agent
12/27/2006	CN1883451A A sustained-release anticancer injection containing angiogenesis inhibitor and synergist thereof
12/27/2006	CN1883444A Application of paeonol in preparation of whitening and freckle-removing cosmetic or pigmentation disease-treating medicine
12/27/2006	CN1883443A A health buccal spray and method for preparing same
12/27/2006	CN1883442A A tooth decay-resistant spray and method for preparing same
12/27/2006	CN1883306A Blood fat-lowering chewing tablet of housefly larvae chitooligosaccharides and method for making same
12/27/2006	CN1883285A Compound sleep assistant health product
12/27/2006	CN1292073C Natural antitumor or antiviral substances and use of the same
12/27/2006	CN1291995C **Tc marked dopamine transport protein developer
12/27/2006	CN1291994C Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
12/27/2006	CN1291993C N-substituted benzothiazolyl-1-substituted phenyl-0,0-dialkyl-alpha-amino phosphonate ester derivatives, their preparation and application
12/27/2006	CN1291990C Biocidal compounds and their preparation
12/27/2006	CN1291988C Triazaspiro [5,5] undecane derivatrives and drugs containing the same as active ingredient
12/27/2006	CN1291987C Process for preparing acid salts of gemifloxacin
12/27/2006	CN1291986C Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions
12/27/2006	CN1291985C Neurotrophin production/secretion promoting agent
12/27/2006	CN1291984C 2-thio-substituted imidazole derivatives and use therof in pharmaceutical industry
12/27/2006	CN1291979C Imidazole compounds and their use as adenosine deaminase inhibitors
12/27/2006	CN1291978C Novel crystal form of 5-hydroxy-1-methyl hydantoin
12/27/2006	CN1291976C Antiretroviral pyridine and quinoline derivatives
12/27/2006	CN1291975C New mandelic acid derivatives and their use as thrombase inhibitors
12/27/2006	CN1291757C Remedy for inflammatory bowel diseases
12/27/2006	CN1291754C Localized anesthesia synergistic delay agent
12/27/2006	CN1291740C Spray for treating rhinitis
12/27/2006	CN1291739C Penetrating liquid for field effect therapeutic equipment
12/27/2006	CN1291731C Chinese medicine for treating pulmonary fibrosis due to chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis
12/27/2006	CN1291724C Preparation and use of injectable isopropyl acrylamide tripolymer as thrombus material and its use
12/27/2006	CN1291723C Extended type 1 chain glycosphingolipids as tumer-associated antigens
12/27/2006	CN1291722C Use of oligoxylose in preparation of medicine for treating diabetes
12/27/2006	CN1291721C Use of allose alcohol in preparation of medicine for diabetes
12/27/2006	CN1291720C Non-sedating barbituric acid derivatives
12/27/2006	CN1291719C Solid dispersion composition
12/27/2006	CN1291718C Remedy for acute myocardial infarction
12/27/2006	CN1291717C Antipruritic
12/27/2006	CN1291716C Nitrendipine dispersion tablet and method for making same
12/27/2006	CN1291715C Pharmaceutical compositions containing epinastine and pseudoephedrine
12/27/2006	CN1291714C Application of phenchlobenpyrrone
12/27/2006	CN1291713C Novel composition with taxane as major component
12/27/2006	CN1291712C Method for producing multiple in-phase mature ovum by diethyl stilbestrol
12/27/2006	CN1291710C Dripping pills preparation and its preparing process
12/27/2006	CN1291665C Fat-reducing health beverage
12/27/2006	CA2549275A1 Neoplasia-specific splice variants and methods
12/26/2006	US7154001 Formate salt of O-desmethyl-venlafaxine
12/26/2006	US7153997 N-hydroxyphenoxyphenyl derivatives of glycine or valine, e.g., N-[3,5-Dichloro-4-(4-hydroxy-3-isopropyl-5-methylphenoxy)benzoyl]glycine; treating metabolic disorders or diseases dependent upon the expression of a T3 regulated gene
12/26/2006	US7153979 For therapy of hepatic disorders
12/26/2006	US7153977 Ligands and methods for preparing same
12/26/2006	US7153975 Boron complexation strategy for use in manipulating 1-acyldipyrromethanes
12/26/2006	US7153970 High purity amlodipine benzenesulfonate and a process for its preparation
12/26/2006	US7153968 For therapy of asthma, chronic bronchitis, chronic obstructive pulmonary disease, eosinophilic granuloma, psoriasis and other benign or malignant proliferative skin diseases, endotoxic shock, laminitis in horses, colic in horses, septic shock, ulcerative colitis, Crohn's disease, reperfusion injury
12/26/2006	US7153967 Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via 1H-imidazo [4,5-C] quinolin-4-phthalimide intermediates
12/26/2006	US7153965 Pharmaceutically acceptable inorganic and organic salts of 5-methylpyrazine-2-carboxylic acid-4-oxide
12/26/2006	US7153964 Pyrimidine compounds
12/26/2006	US7153963 Phenylalanine derivatives
12/26/2006	US7153961 Hydrate of a benzenesulfonate salt of 4-(bis(2-methoxyethyl)amino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-[1,5-a]-pyrazolo-1,3,5-triazine; physical and chemical properties that are both physiologically acceptable and suitable for preparing reproducible pharmaceutical formulations
12/26/2006	US7153959 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis
12/26/2006	US7153958 Farnesyl transferase inhibiting benzoheterocyclic derivatives
12/26/2006	US7153950 For diagnosis of/drugs for inflammatory bowel disease/asthma/ diabetes/arthritis/cirrhosis/skin disorders
12/26/2006	US7153946 Molecular conjugates for use in treatment of cancer
12/26/2006	US7153940 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
12/26/2006	US7153905 Hyperbranched dendron and methods of synthesis and use thereof
12/26/2006	US7153888 Nonvolatile solvent and a stabilizer selected from specified phenolic compounds, hydroxyaromatic acids, catecholes, unsaturated compounds, sulphur compounds, amino acids, tocopherols, vitamins, isoprenoids, and terpenes; for example butylated hydroxytoluene; storage stability, crystallization inhibition
12/26/2006	US7153887 Treatment anti-neutrophil cytoplasmic antibodies-associated vasculitis in a patient resistant to corticosteroid treatment by administering gusperimus or its salt in cycles
12/26/2006	US7153886 Method for treatment of peripheral inflammation of a loop ileal artificial anus
12/26/2006	US7153885 Stolonoxides
12/26/2006	US7153884 C-2′ methylated derivatives of paclitaxel for use as antitumour agents
12/26/2006	US7153883 Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
12/26/2006	US7153882 (Aminocarbonyloxy)-benzofused ring derivatives; Alzheimer*s disease; neurodegenerative disorders
12/26/2006	US7153881 Compounds acting as melanocortin receptor ligands
12/26/2006	US7153880 Substituted diphenyl heterocycles useful for treating HCV infection
12/26/2006	US7153879 E.g., 7,11-Di(hydroxy)-8,8,10,12,16-pentamethyl-3-(1-methyl-2-(methylthiazol-4-yl)ethenyl)-4-aza-17-oxabicyclo(14.1.0)heptadecane-5,9-dione, preferably Form A; anticarcinogenic, -proliferative, -diabetic, -inflammatory agents; viricides; autoimmune diseases; psoriasis; agents; cardiovascular disorders
12/26/2006	US7153878 Substituted thiazoles and oxazoles, e.g., 4-{1-[4-[2-(2-Chloro-6-fluoro-phenyl)-ethyl]-2-(4-trifluoromethyl-phenyl)-thiazol-5-yl]-ethylsulfanyl}-2-methyl-phenoxy)-acetic acid; treating atherosclerosis and diabetes and creating Syndrome X
12/26/2006	US7153877 Chromium bound to niacin and three compounds from the group consisting of (-) hydroxycitric acid, zinc (particularly zinc methionine), trans-reseveratrol, gymnernic acid, selenium, an anthocyanidin, allicin, and fenugreek.
12/26/2006	US7153876 Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation, and their use
12/26/2006	US7153875 Heterocyclic derivatives for the treatment of cancer and other proliferative diseases
12/26/2006	US7153874 For therapy and prophylaxis of of disorders mediated in full or in part by metabotropic glutamate receptor 5, including, e.g. acute, traumatic and chronic degenerative processes of the nervous system, such as Alzheimer's disease, senile dementia, Parkinson's disease, Huntington's chorea
12/26/2006	US7153873 E.g., 7-acetyl-5-tert-butylamino-6-phenyl-imidazo[2,1-b]-thiazol-7-ium chloride; treatment of pain, diarrhea, urinary incontinence, depression, and anxiety
12/26/2006	US7153872 Cancer and fibrotic diseases
12/26/2006	US7153871 Antiinflammatory agents; cognition activators; asthma therapy; antiarthritic agents; side effect reduction
12/26/2006	US7153870 Nicotinamide derivatives useful as PDE4 inhibitors
12/26/2006	US7153869 Substituted amino acids as erythropoietin mimetics
12/26/2006	US7153868 N-(3-(4-substituted-1-piperidinyl)-1-phenylpropyl) substituted sulfonamides as NK-3 receptor antagonists
12/26/2006	US7153867 Use of nitrogen substituted thalidomide analogs for the treatment of macular degenerator
12/26/2006	US7153866 Administering 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl
12/26/2006	US7153865 N-type calcium channel antagonists for the treatment of pain

1 ... 3952 3953 3954 3955 3956 3957 3958 3959 3960 3961 3962 3963 3964 3965 3966 3967 3968 3969 3970 3971 3972 ... 7860